(Q35810041)

10 August 2017

1 reference

title

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders (English)

1 reference

10 August 2017

1 reference

Bryan L Roth

1

1 reference

PubMed ID

15205874

10 August 2017

S Mohammad Hanizavareh

series ordinal

2

1 reference

PubMed ID

15205874

10 August 2017

Andrew E Blum

series ordinal

3

1 reference

10 August 2017

2 December 2003

1 reference

10 August 2017

1 reference

10 August 2017

174

1 reference

10 August 2017

1

1 reference

10 August 2017

17-24

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-003-1683-8

10 August 2017

0 references

cites work

The physiological role of 5-HT2A receptors in working memory

1 reference

12 December 2020

The putative 5-ht6 receptor: localization and function

1 reference

12 December 2020

The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.

1 reference

12 December 2020

Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory

1 reference

12 December 2020

An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning

1 reference

12 December 2020

An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia

1 reference

12 December 2020

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

1 reference

12 December 2020

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

12 December 2020

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

1 reference

12 December 2020

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor

1 reference

12 December 2020

Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors

1 reference

12 December 2020

The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain

1 reference

12 December 2020

The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease

1 reference

12 December 2020

SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties

1 reference

12 December 2020

Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.

1 reference

12 December 2020

5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites

1 reference

12 December 2020

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

1 reference

12 December 2020

The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro.

1 reference

12 December 2020

Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis.

1 reference

12 December 2020

Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia

1 reference

12 December 2020

Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats.

1 reference

12 December 2020

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

12 December 2020

N-methyl-D-aspartate (NMDA) receptors in the ventral tegmental area: subcellular distribution and colocalization with 5-hydroxytryptamine(2A) receptors

1 reference

12 December 2020

Molecular biology of serotonin receptors structure and function at the molecular level

1 reference

12 December 2020

In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate

1 reference

12 December 2020

Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.

1 reference

12 December 2020

Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells

1 reference

12 December 2020

Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor

1 reference

12 December 2020

Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors

1 reference

12 December 2020

Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry.

1 reference

12 December 2020

Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover

1 reference

12 December 2020

The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist

1 reference

12 December 2020

M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex

1 reference

12 December 2020

Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry

1 reference

12 December 2020

Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain

1 reference

12 December 2020

M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats

1 reference

12 December 2020

5-hydroxytryptamine-sensitive adenylate cyclase activity in brain synaptosomal membrane preparations

1 reference

12 December 2020

Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications

1 reference

12 December 2020

Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist

1 reference

12 December 2020

Review article: the complexity of drug development for irritable bowel syndrome

1 reference

12 December 2020

A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction

1 reference

12 December 2020

A review of central 5-HT receptors and their function

1 reference

12 December 2020

Multiple serotonin receptors: clinical and experimental aspects

1 reference

12 December 2020

One hundred years of schizophrenia: a meta-analysis of the outcome literature.

1 reference

12 December 2020

Cognition, schizophrenia, and the atypical antipsychotic drugs

1 reference

12 December 2020

5-hydroxytryptamine2A receptor inverse agonists as antipsychotics

1 reference

12 December 2020

Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group

1 reference

12 December 2020

Involvement of 5-HT6 receptors in nigro-striatal function in rodents

1 reference

12 December 2020

Do specific neurocognitive deficits predict specific domains of community function in schizophrenia?

1 reference

12 December 2020

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

1 reference

12 December 2020

Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.

1 reference

12 December 2020

5-HT4 receptor modulation of acetylcholine outflow in guinea pig brain slices

1 reference

12 December 2020

Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells.

1 reference

12 December 2020

Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.

1 reference

12 December 2020

Subcellular distribution of 5-hydroxytryptamine2A and N-methyl-D-aspartate receptors within single neurons in rat motor and limbic striatum

1 reference

12 December 2020

Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo

1 reference

12 December 2020

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

1 reference

12 December 2020

The organization of serotonergic projections to cerebral cortex in primates: Retrograde transport studies

1 reference

12 December 2020

Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins

1 reference

12 December 2020

Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants

1 reference

12 December 2020

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

12 December 2020

The organization of serotonergic projections to cerebral cortex in primates: Regional distribution of axon terminals

1 reference

12 December 2020

Structure and function of the brain serotonin system

1 reference

12 December 2020

Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study

1 reference

12 December 2020

Dual effects of 5-HT4 receptor activation on GABA release from guinea pig hippocampal slices

1 reference

12 December 2020

A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.

1 reference

12 December 2020

The effect of intravenous ranitidine and metoclopramide on behavior, cognitive function, and affect.

1 reference

12 December 2020

Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

1 reference

12 December 2020

Does cAMP response element-binding protein have a pivotal role in hippocampal synaptic plasticity and hippocampus-dependent memory?

1 reference

12 December 2020

5HT antagonists attenuate MK801-impaired radial arm maze performance in rats.

1 reference

12 December 2020

Drugs which antagonize 5-hydroxytryptamine

1 reference

12 December 2020

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

1 reference

12 December 2020

Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?

1 reference

12 December 2020

Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex.

1 reference

12 December 2020

Clozapine--a serotonin antagonist?

1 reference

12 December 2020

BIMU1 increases associative memory in rats by activating 5-HT4 receptors.

1 reference

12 December 2020

Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017.

1 reference

12 December 2020

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

1 reference

12 December 2020

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

1 reference

12 December 2020

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

1 reference

12 December 2020

5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex

1 reference

12 December 2020

Multiplicity of mechanisms of serotonin receptor signal transduction

1 reference

12 December 2020

Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.

1 reference

12 December 2020

The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein.

1 reference

12 December 2020

10.1007/S00213-003-1683-8

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15205874